New Treatment for IDH mt Gliomas

episode

Neurology® Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Booked out doesn't mean you're ready for an associate OD 23 min · 23 Sep 2026 · The Optometry Success Podcast

The lessons to be learned from the Lucy Letby case 12 min · 23 Sep 2026 · Today with David McCullagh

Trump Threatens to ‘Annihilate’ Iran 29 min · 23 Sep 2026 · Start Here

5AM ET 09/23/2026 Newscast 3 min · 23 Sep 2026 · Fox News Hourly Update

Coming Soon … What Happened to Her 1 min · 23 Sep 2026 · What Happened to Her

I Left My Fiancé, My Church and My Shame 36 min · 23 Sep 2026 · Modern Love

Report any issue

Source

Recorded20 Jul 2023

Publisherneurology.libsyn.com ↗

Handlerec:5447560

Show notes

Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas. Read the related article in The New England Journal of Medicine. Visit NPUb.org/Podcast for associated article links.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in